---
figid: PMC9437959__mmr-26-04-12834-g05
pmcid: PMC9437959
image_filename: mmr-26-04-12834-g05.jpg
figure_link: /pmc/articles/PMC9437959/figure/f6-mmr-26-04-12834/
number: Figure 6
figure_title: ''
caption: 'Candesartan attenuates microglial activation in morphine-induced BV2 cells
  via peroxisome proliferator-activated receptor-γ/AMP-activated protein kinase signaling.
  (A) Immunofluorescence staining detected the expression of IBA-1. The expression
  levels of IBA-1 were detected by (B) reverse transcription-quantitative PCR and
  (C) western blotting. ***P<0.001 vs. control; ###P<0.001 vs. morphine (200 µM);
  @@P<0.01, @@@P<0.001 vs. morphine (200 µM) + candesartan (5 µmol/l). IBA-1, ionized
  calcium-binding adaptor molecule 1.'
article_title: Angiotensin II receptor type 1 blocker candesartan improves morphine
  tolerance by reducing morphine-induced inflammatory response and cellular activation
  of BV2 cells via the PPARγ/AMPK signaling pathway.
citation: Wenxin Zhao, et al. Mol Med Rep. 2022 Oct;26(4):318.
year: '2022'

doi: 10.3892/mmr.2022.12834
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos

keywords:
- morphine tolerance
- angiotensin II receptor type 1
- candesartan
- inflammation
- BV2 cells
- PPARγ/AMPK signaling

---
